---

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

In 2006, Robert joined Amgen as Vice President of Operations Strategy. He was appointed to the Amgen Board of Directors in October 2011, and became Chairman in January 2013, and CEO in May 2012. Before Amgen, he was a managing director at Morgan Stanley in London. In 2017, Robert was elected PhRMA board chairman-elect.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018